{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:08:02Z","timestamp":1776121682659,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jiph.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T16:19:13Z","timestamp":1436113153000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine"],"prefix":"10.1016","volume":"9","author":[{"given":"Cristina","family":"Stasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Voller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2015.05.004_bib0175","unstructured":"World Health Organization. Resolutions. WHA63.18. Available: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63-REC1\/WHA63_REC1-en.pdf [accessed 22.09.10]."},{"key":"10.1016\/j.jiph.2015.05.004_bib0180","series-title":"Guidelines for the screening care and treatment of persons with hepatitis C infection","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.jiph.2015.05.004_bib0185","unstructured":"World Health Organization, 2002. Available: http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/index4.html"},{"key":"10.1016\/j.jiph.2015.05.004_bib0190","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ijc.20507","article-title":"Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus","volume":"112","author":"Tanaka","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jiph.2015.05.004_bib0195","series-title":"Data and statistics","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jiph.2015.05.004_bib0200","unstructured":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/154590\/1\/9789241549059_eng.pdf?ua=1"},{"key":"10.1016\/j.jiph.2015.05.004_bib0205","series-title":"Hepatitis B","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.jiph.2015.05.004_bib0210","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/hep.22929","article-title":"Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence","volume":"49","author":"Taylor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jiph.2015.05.004_bib0215","series-title":"Hepatitis C","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.jiph.2015.05.004_bib0220","series-title":"Hepatitis B","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.jiph.2015.05.004_bib0225","unstructured":"World Health Organization. Fact sheet N\u030a204. Updated March 2015. Hepatitis B. Available: http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/"},{"key":"10.1016\/j.jiph.2015.05.004_bib0230","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jiph.2015.05.004_bib0235","unstructured":"World Health Organization. Weekly epidemiological record. Available: http:\/\/www.who.int\/wer\/2009\/wer8440.pdf [accessed 2.10.09]."},{"key":"10.1016\/j.jiph.2015.05.004_bib0240","series-title":"Global health observatory data repository","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.jiph.2015.05.004_bib0245","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/528687","article-title":"National surveillance system for acute viral hepatitis (SEIEVA) collaborating group acute hepatitis b 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges","volume":"46","author":"Mele","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2015.05.004_bib0250","unstructured":"Centre for Disease Prevention and Control (CDC). Guidelines for viral hepatitis surveillance and case management. Available: http:\/\/www.cdc.gov\/hepatitis\/Statistics\/SurveillanceGuidelines.htm [accessed 24.05.13]"},{"issue":"May","key":"10.1016\/j.jiph.2015.05.004_bib0255","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJMp1400160","article-title":"Treating hepatitis C in lower-income countries","volume":"370","author":"Jayasekera","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2015.05.004_bib0260","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2893.2003.00403.x","article-title":"Italian Hepanet Group long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon","volume":"10","author":"Toccaceli","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jiph.2015.05.004_bib0265","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.dld.2013.03.023","article-title":"Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C","volume":"45","author":"Stasi","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jiph.2015.05.004_bib0270","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.3748\/wjg.v19.i47.8895","article-title":"Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence","volume":"19","author":"Tan","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiph.2015.05.004_bib0275","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.gcb.2009.06.003","article-title":"Analogs and fibrosis regression in hepatitis B","volume":"33","author":"Bouli\u00e8re","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jiph.2015.05.004_bib0280","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.12.020","article-title":"A new role for an old marker HBsAg","volume":"52","author":"Brunetto","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2015.05.004_bib0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12072-012-9343-x","article-title":"B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients","volume":"7","author":"Marcellin","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jiph.2015.05.004_bib0290","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gutjnl-2011-301096","article-title":"Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?","volume":"61","author":"Janssen","year":"2012","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.jiph.2015.05.004_bib0295","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0168-8278(14)60070-2","article-title":"Sofosbuvir and ribavirin for the treatment of chronic HCV with cirrhosis and portal hypertension with and without decompensation: early virological response","volume":"60","author":"Afdhal","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2015.05.004_bib0300","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries","volume":"58","author":"Hill","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2015.05.004_bib0305","unstructured":"Sofosbuvir (Sovaldi) \u2013 Treatment \u2013 Hepatitis C Online. Available: http:\/\/www.hepatitisc.uw.edu\/page\/treatment\/drugs\/sofosbuvir-drug"},{"key":"10.1016\/j.jiph.2015.05.004_bib0310","unstructured":"Simeprevir (Olysio) \u2013 Treatment \u2013 Hepatitis C Online. Available: http:\/\/www.hepatitisc.uw.edu\/page\/treatment\/drugs\/simeprevir-drug"},{"key":"10.1016\/j.jiph.2015.05.004_bib0315","article-title":"New treatments for hepatitis C virus: strategies for achieving universal access","volume":"8","author":"Pauline Londeix","year":"2014","journal-title":"Medicins du Monde"},{"key":"10.1016\/j.jiph.2015.05.004_bib0320","unstructured":"Gilead offers Egypt new hepatitis C drug at 99 percent discount. Available: http:\/\/www.reuters.com\/article\/2014\/03\/21\/us-hepatitis-egypt-gilead-sciences-idUSBREA2K1VF20140321 [accessed 21.03.14]."},{"key":"10.1016\/j.jiph.2015.05.004_bib0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/liv.12423","article-title":"HCV direct-acting antiviral agents: the best interferon-free combinations","volume":"34","author":"Schinazi","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jiph.2015.05.004_bib0330","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1756283X14524614","article-title":"B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal","volume":"7","author":"Vallet-Pichard","year":"2014","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jiph.2015.05.004_bib0335","first-page":"3","article-title":"This is hepatitis \u2013 it is closer than you think","volume":"136","author":"Fung","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jiph.2015.05.004_bib0340","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fvl.14.36","article-title":"Strategies to eliminate HBV infection","volume":"9","author":"Kapoor","year":"2014","journal-title":"Future Virol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603411500101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603411500101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T03:57:52Z","timestamp":1537502272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603411500101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S187603411500101X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2015.05.004","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.","name":"copyright","label":"Copyright"}]}}